Shares of multi-specialty telehealth platform, Hims & Hers Health, Inc. (HIMS) are rising more than 19% Tuesday morning after reporting nearly 100% revenue growth in the third quarter. Fourth-quarter as well as full-year revenue outlook came in above analysts' view.
Quarterly revenue increased 95% year-over-year to $144.8 million.
The company, however, reported a loss of 18.84 million or $0.09 per share for the third quarter, wider than 15.9 million or $0.08 per share last year, on higher expenses. Analysts on average were expecting a loss of $0.10 per share.
For the fourth quarter, Hims & Hers Health expects revenue to be in the range of $159 million to $162 million. The consensus estimate stands at $134.3 million.
For the full year, revenue is expected between $519 million and $522 million. Analysts expect revenue of $479.9 million for the year.
HIMS, currently at $5.50, has traded in the range of $2.72-$8.63 in the last 52 weeks.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.